Personalizing Adoptive Cell Transfer for Solid Tumors: Towards a New Patient-tailored Treatment Option
NCT06922266 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 20
Last updated 2025-04-10
Summary
This is a monocentric prospective observational study. This study will include patients with a diagnosis of non-small cell lung cancer for the collection of blood and tissue specimens.
Conditions
- Carcinoma, Non-Small-Cell Lung
Sponsors & Collaborators
-
Fondazione Umberto Veronesi
collaborator OTHER -
Ospedale San Raffaele
lead OTHER
Principal Investigators
-
Chiara M Cattaneo, PhD · IRCCS Ospedale San Raffaele
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-05-01
- Primary Completion
- 2029-04-30
- Completion
- 2029-04-30
More Related Trials
-
Validation of Molecular Diagnostic Thecnologies for Lung Cancer Patients.
NCT03220230 ·Status: COMPLETED
-
Tumor Molecular Profiling in Early Phase Clinical Trials
NCT04510766 ·Status: RECRUITING
-
Efficacy and Safety of Chemoimmunotherapy and Carbon Ion Radiotherapy in Unresectable Locally Advanced Non-small Cell Lung Cancer
NCT07035860 ·Status: NOT_YET_RECRUITING
-
Perioperative and Postoperative Circulating Tumor Cell Monitoring in Different Stage of NSCLC
NCT07186855 ·Status: COMPLETED
-
Broncho-Vascular Lung Sparing Reconstructions and Pneumonectomies in Patients With Non Small Cell Lung Cancer
NCT06835231 ·Status: ACTIVE_NOT_RECRUITING
-
Enumeration of Circulating Tumour Cells (CTCs) in Patients With Advanced Solid Malignancy Using Complementary Metal Oxide Semiconductor (CMOS) Technology
NCT01596452 ·Status: UNKNOWN
-
Phase 2 Study of VGT-309 in Lung Cancer
NCT05400226 ·Status: COMPLETED ·Phase: PHASE2
-
Clinical Significance of Circulating Tumour Cells in Resectable Lung Cancer Patients
NCT05619562 ·Status: COMPLETED
-
Studies of Phenotypic and Functional Characteristics of Circulating Neutrophil Subpopulations in Patients With Lung Cancer
NCT06244355 ·Status: RECRUITING
-
Lung Cancer Organoids and Patient Derived Tumor Xenografts
NCT05092009 ·Status: RECRUITING
-
Exploratory Biomarker Analysis of Neoadjuvant Chemoimmunotherapy Followed by Pulmonary Resection in Stage II-III Non-Small Cell Lung Cancer
NCT06907160 ·Status: RECRUITING
-
The Utility of Circulating Tumor Cells as Confirmation of Pathologic Diagnosis in Patients With Suspected Early Stage Non-small Cell Lung Cancer
NCT02380196 ·Status: COMPLETED
-
Collection of Blood Samples in Patients With Non-small Cell Lung Cancer
NCT03492801 ·Status: TERMINATED
-
Tumor Rebiopsy During Progression Under Immunotherapy for Patients With Lung Cancer
NCT04300062 ·Status: RECRUITING ·Phase: NA
-
Lung Cancer Detection by Measuring Monocyte Activity
NCT02090166 ·Status: UNKNOWN ·Phase: NA
-
Detection of Circulating Tumour Cells, Spread Through Air Space in Patients With Lung Cancer
NCT06833632 ·Status: RECRUITING
-
Clinical and Molecular Study With Digital Support of Patients With Inoperable Lung Cancer
NCT05372081 ·Status: UNKNOWN
-
Generation of Lung Tumor Organoids From Patients Undergoing Diagnostic Bronchoscopy
NCT06239584 ·Status: RECRUITING ·Phase: NA
-
Characteristics of Advanced LUNG CANCER at the tIme of Diagnosis in a Large Italian Cohor
NCT06076005 ·Status: RECRUITING
-
CirculAting Tumor DNA in Patients DIagnosed With Lung Metastasis From Colorectal Cancer: candiDate Selection for Local AblaTive thErapy
NCT04704960 ·Status: UNKNOWN
-
Using ctDNA to Determine Therapies for Lung Cancer
NCT04966663 ·Status: RECRUITING ·Phase: PHASE2
-
CTC in Lung Caner Patients With Bone Metastases
NCT04568291 ·Status: UNKNOWN ·Phase: NA
-
Evaluation of Stents to Open Restricted Airways in Patients With Centrally Placed Non-small Cell Lung Cancer
NCT01003522 ·Status: UNKNOWN ·Phase: PHASE3
-
Survival Analysis and Prognostic Biomarker Exploration of Postoperative Adjuvant Therapy Patterns in Patients With Non-small Cell Lung Cancer After Neoadjuvant Immunotherapy
NCT07256002 ·Status: ACTIVE_NOT_RECRUITING
-
Immune Checkpoint Inhibitors in Advanced Non-small Cell Lung Cancer and Discovery of New Biomarkers
NCT03658460 ·Status: COMPLETED